For centuries, agriculture has advanced by adopting whatever tools allowed farmers to do more with less — and gene editing is simply the latest in that unbroken line. What distinguishes this moment is that the technology has already crossed from laboratory promise into lived reality: seedless fruit on grocery shelves, PRRS-resistant pigs awaiting commercial release, and cancer patients years removed from a single curative infusion. CRISPR is not arriving; it has arrived, and the question now is not whether it will reshape food production and medicine, but how quietly and completely it will do